Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RhEGF in Collagen Membrane for Gingival Recession
NCT04375618Phase 1Unknown
- Sponsor
- SVS Institute of Dental Sciences
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of nepidermin in gingival recession (2 arms), sponsored by SVS Institute of Dental Sciences. Primary endpoint: Recession depth at 6 months. Status: unknown.
02
Drugs
nepidermin
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT04375618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375618.